Position in OGEN
as of Dec 31, 2025
· filed Feb 17, 2026
Position Value
$48,157
-$29,071 QoQ
Shares Held
61,740
+4.7% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SABBY MANAGEMENT, LLC holds $1,712,666 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BDRX |
Biodexa Pharmaceuticals Plc
|
257,472 | $795,588 | |
| 2 | BCTX |
BriaCell Therapeutics Corp.
|
73,915 | $309,703 | |
| 3 | MBRX |
Moleculin Biotech, Inc.
|
75,021 | $171,798 | |
| 4 | CANF |
Can-Fite BioPharma Ltd.
|
42,559 | $131,932 | |
| 5 | REVB |
Revelation Biosciences, Inc.
|
99,432 | $119,318 | |
| 6 | CLDI |
Calidi Biotherapeutics, Inc.
|
434,903 | $103,941 | |
| 7 | LYRA |
Lyra Therapeutics, Inc.
|
104,059 | $51,103 | |
| 8 | TPST |
Tempest Therapeutics, Inc.
|
17,856 | $29,283 |
All Filings in OGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $48,157 | 61,740 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $77,228 | 58,953 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||